Cancer Lett 2022 May 21:215750. Epub 2022 May 21.
Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, PR China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, 200032, PR China; Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, 200032, PR China. Electronic address:
Immune checkpoint blockade (ICB) therapy is an important treatment option for individuals with cancer, but it has certain limitations. Identifying a better target that can overcome tumor immune escape and stimulate T cell activity is critical. This research aimed to delve into the molecular mechanism underlying the immunoregulatory function of metadherin (MTDH), which is a novel and potential therapeutic target in hepatocellular cancer (HCC). Read More